Hikma Pharmaceuticals (GB:HIK) has released an update.
Hikma Pharmaceuticals PLC has disclosed transactions by a key managerial figure, Bassam Kanaan, involving the sale of company shares. Kanaan sold 35,000 shares at £19.60 each and another 10,000 shares at £20.25 each on the London Stock Exchange. The transactions, initially notified and totaling nearly £888,500, were executed on the 8th and 9th of August 2024.
For further insights into GB:HIK stock, check out TipRanks’ Stock Analysis page.
